What is the incidence of bile acid diarrhea in patients after terminal ileal resection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Incidence of Bile Acid Diarrhea After Terminal Ileal Resection

Bile acid diarrhea occurs in over 80% of patients following terminal ileal resection, with the vast majority (91-100%) demonstrating severe bile acid malabsorption on diagnostic testing. 1, 2

Documented Incidence Rates

The incidence is remarkably high and well-established across multiple guideline sources:

  • 91-100% of patients with terminal ileal resection for Crohn's disease demonstrate abnormal SeHCAT retention (<15%), indicating at least mild bile acid malabsorption 1
  • 87-92% have severe malabsorption (SeHCAT retention <10%) 1
  • 76-82% of patients with terminal ileal resection for reasons other than Crohn's disease develop bile acid diarrhea 1
  • 97% of Crohn's patients with ileal resection had SeHCAT retention <10%, and 93% had retention <5% in one cohort study 3

Why This Occurs

The terminal ileum contains the apical Na+-dependent bile salt transporter responsible for reabsorbing over 90% of bile acids 4, 5. When this segment is resected, unabsorbed bile acids reach the colon where they stimulate fluid, mucus, and sodium secretion while increasing gastrointestinal motility 2. This mechanism is nearly universal after terminal ileal resection, making bile acid diarrhea the expected outcome rather than a complication 1.

Correlation with Resection Length

There is a modest but significant correlation between the length of ileal resection and severity of bile acid malabsorption (Spearman's rho -0.392, P=0.0001) 3. However, even relatively short resections can cause severe symptoms, as the active transport mechanisms are highly localized to the terminal ileum 4.

Clinical Implications

Diagnostic testing may not be necessary before initiating treatment in patients with documented terminal ileal resection, given the extremely high pretest probability 1. The Canadian Association of Gastroenterology specifically notes that in patients with ileal resection, there is an extremely high risk of bile acid diarrhea, and diagnostic testing may not be necessary before treatment 1.

Response to bile acid sequestrants occurs in approximately 67% of patients with ileal resection, though this response rate is not dependent on the severity of SeHCAT retention values 3. First-line treatment with cholestyramine 4g once or twice daily, titrated to 2-12g/day based on response, is recommended 2.

Important Caveat

Do not use bile acid sequestrants if the patient has extensive ileal resection (>100 cm) due to risk of worsening steatorrhea from binding of remaining bile acids needed for fat absorption 6. In these cases, the primary problem shifts from bile acid diarrhea to fat malabsorption 7.

References

Guideline

Bile Acid Diarrhea Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Advances in understanding of bile acid diarrhea.

Expert review of gastroenterology & hepatology, 2014

Guideline

Bile Acid Diarrhea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How should I diagnose and treat bile acid diarrhea in an adult with chronic watery diarrhea, especially after cholecystectomy, ileal resection, or Crohn’s disease involving the terminal ileum, when a low‑fat diet has failed?
What are the clinical consequences of terminal ileal malabsorption?
How should cholestyramine be used to treat bile‑acid malabsorption–related diarrhea?
Is bile acid diarrhea typically associated with acid reflux in adults with a history of gastrointestinal issues?
In a patient with Crohn's disease status post small bowel resection leaving 90 cm of intestine and an intact colon, who develops persistent diarrhea after starting oral feeding, which of the following would worsen his diarrhea: fat restriction, bile‑acid resin, or proton‑pump inhibitor?
What is the recommended use of Naturalyte (bicarbonate-based dialysate) for a patient with impaired renal function requiring dialysis?
What is the approach to a physical exam for a rash in a healthy adult?
What should a SOAP note include for a patient presenting with a rash?
What are the key components of a physical exam for a patient suspected of having cauda equina syndrome?
What is the recommended dose of Semaglutide (glucagon-like peptide-1 receptor agonist) for a patient with mast cell activation syndrome?
What is the STAMPEDE (Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy) trial and its findings on the use of abiraterone (abiraterone acetate) plus prednisone in combination with androgen deprivation therapy (ADT) for men with high-risk or metastatic prostate cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.